Why pre-screen biofabricators before the interview
The printer is not the limiting factor. Cells more than a few hundred microns from a nutrient supply die, which is why almost everything in this field is thin, small or perfused. Biofabricators worth hiring lead with that constraint and can say how thick a construct they kept viable and for how long. A short screen asks exactly that, which separates bench experience from familiarity with the literature.
What actually matters when screening Tissue Engineering Biofabricator candidates
- 01
Technique and experimental design
Check hands-on command of extrusion, inkjet or DLP bioprinting: bioink rheology tuning, crosslinking chemistry, print parameter matrices, and viability assays such as Live/Dead or alamarBlue.
- 02
Results that went somewhere
Probe constructs that left the bench: vascularised tissue models, cartilage or skin grafts, organ-on-chip units, plus ISO 10993 testing, animal studies or IND-enabling packages.
- 03
Troubleshooting and reproducibility
Test debugging of failed prints and cultures: nozzle clogging, filament collapse, contamination in perfusion bioreactors, batch variability in GelMA or decellularised ECM inks.
- 04
Documentation and collaboration
Assess ELN and batch record discipline, SOP authoring, cleanroom or GMP documentation, and coordination with cell biologists, materials chemists and quality or regulatory colleagues.
Pre-screening questions to ask Tissue Engineering Biofabricator candidates
12 questions grouped by what they test. Ask the same set in every screen and score answers on a consistent scale, or send them as an async video screen and compare answers side by side.
Constructs they made
3 questions01Can you discuss your experience designing and running biofabrication work?
Listen forConstructs they fabricated with dimensions, cell types and viability duration stated concretely.
Work described without dimensions or viability, or fabrication performed entirely by others.
02Do you have hands-on experience with bioprinters and related laboratory equipment?
Listen forPrinters operated and calibrated by them, with print parameters tuned for specific bioinks.
Equipment operated by a technician, or print parameters used at default settings.
03Can you give an example of solving a significant problem on a project?
Listen forA real difficulty such as poor cell viability after printing or a construct that would not hold shape.
Challenges described as resourcing, or no fabrication problem they had to work through.
Materials and cells
3 questions04Do you have experience with both scaffold-based and self-assembly approaches?
Listen forBoth understood with the trade-offs described, and the choice justified for a particular tissue.
One approach used regardless of application, or the trade-offs between them not understood.
05Do you have experience sourcing and working with stem cells?
Listen forSourcing, characterisation and differentiation all handled properly, with consent and provenance respected throughout.
Cell provenance unclear, or differentiation state assumed rather than characterised.
06How do you approach material selection for biofabrication?
Listen forMaterials chosen for printability, mechanical properties and cell compatibility together, not just one.
Materials chosen for printability alone, or degradation rate not matched to tissue formation.
Vascularisation faced
3 questions07How do you approach the challenge of vascularisation?
Listen forTreated as the central constraint, with the diffusion limit stated and perfusion or channels described.
Vascularisation described as an engineering detail, or the diffusion limit not acknowledged.
08Do you have experience with mechanical testing of fabricated tissues?
Listen forMechanical properties measured and compared against native tissue, with the gap stated honestly.
Mechanical properties assumed from the material, or never compared against real tissue.
09Can you discuss your experience with laboratory and animal models?
Listen forBoth used appropriately, with the limitations of culture models for predicting in vivo behaviour understood.
Culture results presented as predictive, or animal work described without approval processes.
Safety and records
3 questions10What steps have you taken to ensure safety and regulatory compliance?
Listen forBiological safety, tissue provenance and ethical approvals all treated as prerequisites rather than paperwork.
Approvals described as delays, or human tissue handled without documented consent and approval.
11Do you have experience planning and running research in this field?
Listen forStudies designed with controls and replication, with reproducibility across batches actually checked.
Single constructs reported as results, or batch-to-batch variability never measured.
12What software or digital tools do you use in design and fabrication?
Listen forDesign files and print parameters versioned, so a construct can be reproduced exactly later.
Parameters adjusted without recording, or prints that cannot be reproduced from stored files.
How to score responses
Score every candidate on the same four criteria immediately after the screen. At this stage you are shortlisting for panel interviews, not making the final call.
Technique and experimental design
35%5Names specific printers (BIO X, RegenHU), explains shear stress versus viability trade-offs, and designs printability studies with defined controls.
Results that went somewhere
25%5Cites named constructs advanced to preclinical or partner handoff, with cell densities, culture durations and histology or mechanical data.
Troubleshooting and reproducibility
25%5Walks through a root cause chase (crosslinker lot, endotoxin, incubator CO2) and the controls that restored batch-to-batch reproducibility.
Documentation and collaboration
15%5Writes SOPs others follow, keeps traceable batch records to material lot level, and translates fabrication limits to biology and regulatory teams.
Cells more than a few hundred microns from a nutrient supply die. A one-way video screen asks how thick a viable construct they made.
Try it on HirevireScreening FAQ
Process basics
How long should a pre-screening round for this role take?
Fifteen minutes across eight to ten questions, answered async. Enough to establish constructs they fabricated, test their materials and cell knowledge, and check safety and records.
How much cell biology should I expect?
Substantial. Someone who can operate a bioprinter but cannot maintain and characterise the cells will produce constructs that look right under a microscope and are not viable.
Evaluating answers
What is the strongest signal when screening this role?
The thickness and viability of something they actually made. Bench practitioners give numbers. Anyone describing capability without dimensions has read about the field rather than worked in it.
How do I judge their honesty about the field?
Ask about vascularisation. Real answers treat it as the central unsolved problem. Anyone who describes it as an engineering detail is overstating where the field currently is.
























